Michael Bartoschek

affiliated with the university
More filtering options
  1. 2019
  2. 2018
  3. Microenvironmental control of breast cancer subtype elicited through paracrine platelet-derived growth factor-CC signaling

    Roswall, P., Bocci, M., Bartoschek, M., Li, H., Kristiansen, G., Jansson, S., Lehn, S., Sjölund, J., Reid, S., Larsson, C., Eriksson, P., Anderberg, C., Cortez, E., Saal, L. H., Orsmark-Pietras, C., Cordero, E., Haller, B. K., Häkkinen, J., Burvenich, I. J. G., Lim, E. & 7 othersOrimo, A., Mattias Höglund, Lisa Rydén, Moch, H., Scott, A. M., Eriksson, U. & Kristian Pietras, 2018 Mar 12, In : Nature Medicine. 24, p. 463–473

    Research output: Contribution to journalArticle

  4. Exploring functional subsets of cancer-associated fibroblasts

    Michael Bartoschek, 2018, Lund: Lund University, Faculty of Medicine. 83 p.

    Research output: ThesisDoctoral Thesis (compilation)

  5. Long-peptide vaccination with driver gene mutations in p53 and Kras induces cancer mutation-specific effector as well as regulatory T cell responses

    Quandt, J., Schlude, C., Michael Bartoschek, Will, R., Cid-Arregui, A., Schölch, S., Reissfelder, C., Weitz, J., Schneider, M., Wiemann, S., Momburg, F. & Beckhove, P., 2018, In : OncoImmunology. 7, 12, e1500671.

    Research output: Contribution to journalArticle

  6. 2016
  7. Cartilage oligomeric matrix protein contributes to the development and metastasis of breast cancer

    E Englund, M Bartoschek, Reitsma, B., Jacobsson, L., Escudero-Esparza, A., Orimo, A., K Leandersson, C Hagerling, A Aspberg, Storm, P., Okroj, M., H Mulder, K Jirström, K Pietras & A M Blom, 2016, In : Oncogene. 35, 43, p. 5585-5596 12 p.

    Research output: Contribution to journalArticle

  8. Complement inhibitor CSMD1 acts as tumor suppressor in human breast cancer

    Escudero-Esparza, A., Michael Bartoschek, Chrysostomi Gialeli, Okroj, M., Owen, S., Karin Jirström, Orimo, A., Jiang, W. G., Kristian Pietras & Anna M. Blom, 2016, In : Oncotarget. 7, 47, p. 76920-76933 14 p.

    Research output: Contribution to journalArticle

  9. 2015
  10. Endothelial ALK1 Is a Therapeutic Target to Block Metastatic Dissemination of Breast Cancer.

    Cunha, S. I., Matteo Bocci, Lövrot, J., Eleftheriou, N., Roswall, P., Cordero, E., Lindström, L., Michael Bartoschek, Haller, B. K., Pearsall, R. S., Mulivor, A. W., Kumar, R., Christer Larsson, Bergh, J. & Kristian Pietras, 2015, In : Cancer Research. 75, 12, p. 2445-2456

    Research output: Contribution to journalArticle